130 related articles for article (PubMed ID: 8138943)
1. Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.
Piercey MF; Smith MW; Lum-Ragan JT
J Pharmacol Exp Ther; 1994 Mar; 268(3):1297-303. PubMed ID: 8138943
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
Piercey MF; Tang AH; Lahti RA; VonVoigtlander PF; Schreur PJ; McCall RB; Lum-Ragan JT; Hoffmann WE; Franklin SR; Code RA
J Pharmacol Exp Ther; 1994 Mar; 268(3):1304-10. PubMed ID: 7908053
[TBL] [Abstract][Full Text] [Related]
3. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
Martin LP; Jackson DM; Wallsten C; Waszczak BL
J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
[TBL] [Abstract][Full Text] [Related]
5. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
[TBL] [Abstract][Full Text] [Related]
6. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
7. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological evidence that spiperone is an antagonist of 5-HT1A receptors in the dorsal raphe nucleus.
Lum JT; Piercey MF
Eur J Pharmacol; 1988 Apr; 149(1-2):9-15. PubMed ID: 2969339
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K
J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598
[TBL] [Abstract][Full Text] [Related]
11. Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus.
Szabo ST; Blier P
Synapse; 2001 Dec; 42(4):203-12. PubMed ID: 11746719
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex.
Rigdon GC; Weatherspoon JK
J Pharmacol Exp Ther; 1992 Nov; 263(2):486-93. PubMed ID: 1432685
[TBL] [Abstract][Full Text] [Related]
13. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats.
Pruus K; Skrebuhhova-Malmros T; Rudissaar R; Matto V; Allikmets L
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):833-46. PubMed ID: 11220492
[TBL] [Abstract][Full Text] [Related]
14. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
15. Effects of maternal ethanol consumption and buspirone treatment on 5-HT1A and 5-HT2A receptors in offspring.
Kim JA; Gillespie RA; Druse MJ
Alcohol Clin Exp Res; 1997 Oct; 21(7):1169-78. PubMed ID: 9347075
[TBL] [Abstract][Full Text] [Related]
16. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
Hamon M; Fattaccini CM; Adrien J; Gallissot MC; Martin P; Gozlan H
J Pharmacol Exp Ther; 1988 Aug; 246(2):745-52. PubMed ID: 2457083
[TBL] [Abstract][Full Text] [Related]
17. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
[TBL] [Abstract][Full Text] [Related]
18. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra.
Gervais J; Rouillard C
Synapse; 2000 Mar; 35(4):281-91. PubMed ID: 10657038
[TBL] [Abstract][Full Text] [Related]
19. Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; de Montigny C; Blier P
J Pharmacol Exp Ther; 1998 Sep; 286(3):1239-47. PubMed ID: 9732384
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic involvement in haloperidol-induced catalepsy.
Neal-Beliveau BS; Joyce JN; Lucki I
J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]